Go to top of page

Warning message

There is currently a suspension or adjustment to some of our activities due to COVID-19. For full details please visit our Activities in response to COVID-19 information page.

Australian Clinical Dosimetry Service

ARPANSA develops audit for new MRI-Linac
28 April 2020

ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out audits on a new Elekta Unity MRI-Linac in Townsville, Queensland before the treatment of the first patient.

20 June 2017

The national data sets show the dose variation as measured by the ACDS in audits to date excluding follow up audits.

The ACDS Level III humanoid thorax phantom sitting on a reflective table with many cables emitting from the device.
20 June 2017

The Level III audit is an end-to-end test of the radiotherapy treatment pathway.

20 June 2017

The Clinical Advisory Group was assembled by the ACDS to provide technical support and advice to the ACDS.

An ACDS auditor intensly focusing on setting up an ion chamber in a water tank for the Level Ib audit.
20 June 2017

The Level Ib audit offers a more accurate measurement of the Linac output than the Level I audit. ACDS staff visit the facility and perform on-site measurements using ACDS dosimetry equipment.

20 June 2017

The ACDS staff and alumni.

20 June 2017

Publications relevant to the ACDS

A female ACDS auditor setting up the 2D ion chamber array in the Level II solid water phantom.
20 June 2017

The Level II audit is a diagnostic test of the Treatment Planning System performance.

Setup for 6MV OSLD irradiation using a perspex block phantom.
20 June 2017

The Level I mail out audit is an independent measurement of linac output under reference conditions.

Subscribe to RSS - Australian Clinical Dosimetry Service